DNA Vaccine Delivery Technology Shows Promise In Inducing Stronger Immune Responses

Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using a proprietary electroporation-based DNA delivery platform, announced today it has expanded its research license with the International AIDS Vaccine Initiative (IAVI), a leading organization dedicated to ensuring the development of safe and effective preventive HIV vaccines.

Add to: del.icio.us | Digg